A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Clinical trial NCT06783647 · RECRUITING

Trial details

NCT number: NCT06783647
Sponsor: Nanjing Leads Biolabs Co.,Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumour

Start date: 2025-06-11
Primary completion: 2026-12-24
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.